Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema

References

• Balfour JA, Fitton A, Barradell LB. Lornoxicam. A review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions. Drugs. 1996;51(4):639–657. doi:10.2165/00003495-199651040-000088706598
   PubMed Web of Science ®Google Scholar
• Meineke I, Turck D. Population pharmacokinetic analysis of meloxicam in rheumatoid arthritis patients. Br J Clin Pharmacol. 2003;55(1):32–38. doi:10.1046/j.1365-2125.2003.01753.x12534638
   PubMedGoogle Scholar
• Herrmann WA, Geertsen MS. Efficacy and safety of lornoxicam compared with placebo and diclofenac in acute sciatica/lumbo-sciatica: an analysis from a randomised, double‐blind, multicentre, parallel-group study. Int J Clin Pract. 2009;63(11):1613–1621. doi:10.1111/j.1742-1241.2009.02187.x19832818
   PubMedGoogle Scholar
• Lin SZ, Wouessidjewe D, Poelman MC, Duchêne D. In vivo evaluation of indomethacin/cyclodextrin complexes gastrointestinal tolerance and dermal anti-inflammatory activity. Int J Pharm. 1994;106(1):63–67. doi:10.1016/0378-5173(94)90276-3
   Google Scholar
• Yener G, Üner M, Gönüllü Ü, et al. Design of meloxicam and lornoxicam transdermal patches: preparation, physical characterization, ex vivo and in vivo studies. Chem Pharm Bull. 2010;58(11):1466–1473.21048338
   PubMed Web of Science ®Google Scholar
• Kavitha K, Rajendra MM. Design and evaluation of transdermal films of lornoxicam. Int J Pharma Bio Sci. 2011;2(2):54–62.
   Google Scholar
• Ascenso A, Raposo S, Batista C, et al. Development, characterization, and skin delivery studies of related ultradeformable vesicles: transfersomes, ethosomes, and transethosomes. Int J Nanomedicine. 2015;10:5837–5851. doi:10.2147/IJN.S8618626425085
   PubMed Web of Science ®Google Scholar
• Gönüllü Ü, Üner M, Yener G, Karaman EF, Aydoğmuş Z. Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery. Acta Pharmaceutica. 2015;65(1):1–13. doi:10.1515/acph-2015-000925781700
   PubMed Web of Science ®Google Scholar
• Al-Suwayeh SA, Taha EI, Al-Qahtani FM, Ahmed MO, Badran MM. Evaluation of skin permeation and analgesic activity effects of carbopol lornoxicam topical gels containing penetration enhancer. Sci World J. 2014;2014(2):127495. doi:10.1155/2014/127495
   Google Scholar
• Abdel-Mottaleb MM, Neumann D, Lamprecht A. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers. Eur J Pharm Biopharm. 2011;79(1):36–42. doi:10.1016/j.ejpb.2011.04.00921558002
   PubMedGoogle Scholar
• Karande P, Jain A, Mitragotri S. Insights into synergistic interactions in binary mixtures of chemical permeation enhancers for transdermal drug delivery. J Control Release. 2006;115(1):85–93. doi:10.1016/j.jconrel.2006.07.00116935378
   PubMed Web of Science ®Google Scholar
• Barry BW. Mode of action of penetration enhancers in human skin. J Control Release. 1987;6(1):85–97. doi:10.1016/0168-3659(87)90066-6
   Google Scholar
• Murthy SN, Sammeta SM, Bowers C. Magnetophoresis for enhancing transdermal drug delivery: mechanistic studies and patch design. J Control Release. 2010;148(2):197–203. doi:10.1016/j.jconrel.2010.08.01520728484
   PubMedGoogle Scholar
• Henchoz Y, Abla N, Veuthey JL, Carrupt PA. A fast screening strategy for characterizing peptide delivery by transdermal iontophoresis. J Control Release. 2009;137(2):123–129. doi:10.1016/j.jconrel.2009.03.01819348865
   PubMedGoogle Scholar
• Chen H, Zhu H, Zheng J, et al. Iontophoresis-driven penetration of nanovesicles through microneedle-induced skin microchannels for enhancing transdermal delivery of insulin. J Control Release. 2009;139(1):63–72. doi:10.1016/j.jconrel.2009.05.03119481577
   PubMed Web of Science ®Google Scholar
• Vanbever R, Langers G, Montmayeur S, Préat V. Transdermal delivery of fentanyl: rapid onset of analgesia using skin electroporation. J Control Release. 1998;50(1–3):225–235.9685889
   PubMed Web of Science ®Google Scholar
• Bal SM, Kruithof AC, Zwier R, et al. Influence of microneedle shape on the transport of a fluorescent dye into human skin in vivo. J Control Release. 2010;147(2):218–224. doi:10.1016/j.jconrel.2010.07.10420650292
   PubMed Web of Science ®Google Scholar
• Hou D, Xie C, Huang K, Zhu C. The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials. 2003;24(10):1781–1785.12593960
   PubMed Web of Science ®Google Scholar
• Wang JJ, Liu KS, Sung KC. Skin permeation of buprenorphine and its ester prodrugs from lipid nanoparticles: lipid emulsion, nanostructured lipid carriers and solid lipid nanoparticles. J. Microencapsul. 2009;26(8):734–747. doi:10.3109/02652040902746679
   PubMed Web of Science ®Google Scholar
• Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2009;366(1–2):170–184. doi:10.1016/j.ijpharm.2008.10.00318992314
   PubMed Web of Science ®Google Scholar
• Lopes LB, Brophy CM, Furnish E, et al. Comparative study of the skin penetration of protein transduction domains and a conjugated peptide. Pharm Res. 2005;22(5):750–757. doi:10.1007/s11095-005-2591-x15906170
   PubMedGoogle Scholar
• Patlolla RR, Vobalaboina V. Pharmacokinetics and tissue distribution of etoposide delivered in parenteral emulsion. J Pharm Sci. 2005;94(2):437–445. doi:10.1002/jps.2024915614812
   PubMedGoogle Scholar
• Jenning V, Schäferkorting M, Gohla S. Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. J Control Release. 2000;66(3):115–126.10742573
   PubMed Web of Science ®Google Scholar
• Bodade SS, Shaikh KS, Kamble MS, Chaudhari PD. A study on ethosomes as mode for transdermal delivery of an antidiabetic drug. Drug Deliv. 2013;20(1):40–46. doi:10.3109/10717544.2012.75242023311652
   PubMed Web of Science ®Google Scholar
• Ammar HO, Ghorab M, Mahmoud AA, Makram TS, Noshi SH. Topical liquid crystalline gel containing lornoxicam/cyclodextrin complex. J Incl Phenom Macrocycl Chem. 2012;73(1–4):161–175. doi:10.1007/s10847-011-0039-y
   Web of Science ®Google Scholar
• Patel LN, Zaro JL, Shen WC. Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives. Pharm Res. 2007;24(11):1977–1992. doi:10.1007/s11095-007-9303-717443399
   PubMed Web of Science ®Google Scholar
• Desai P, Patlolla RR, Singh M. Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery. Mol Membr Biol. 2010;27(7):247–259. doi:10.3109/09687688.2010.52220321028936
   PubMed Web of Science ®Google Scholar
• Cohenavrahami M, Aserin A, Garti N. H(II) mesophase and peptide cell-penetrating enhancers for improved transdermal delivery of sodium diclofenac. Colloids Surf B Biointerfaces. 2010;77(2):131–138. doi:10.1016/j.colsurfb.2010.01.01320189781
   PubMedGoogle Scholar
• Cohenavrahami M, Libster D, Aserin A, Garti N. Sodium diclofenac and cell-penetrating peptides embedded in HII mesophases: physical characterization and delivery. J Phys Chem B. 2011;115(34):10189–10197. doi:10.1021/jp112067v21749044
   PubMedGoogle Scholar
• Rao S, Barot T, Rajesh KS, Jha LL. Formulation, optimization and evaluation of microemulsion based gel of Butenafine Hydrochloride for topical delivery by using simplex lattice mixture design. J. Pharm Investig. 2016;46(1):1–12. doi:10.1007/s40005-015-0207-y
   Google Scholar
• Zeb A, Qureshi OS, Yu CH, et al. Enhanced anti-rheumatic activity of methotrexate-entrapped ultradeformable liposomal gel in adjuvant-induced arthritis rat model. Int J Pharm. 2017;525(1):92–100. doi:10.1016/j.ijpharm.2017.04.03228428089
   PubMed Web of Science ®Google Scholar
• Schousboe A, Frandsen A, Krogsgaard-Larsen P. Pharmacological and functional characterization of excitatory amino acid mediated cytotoxicity in cerebral cortical neurons. Cell Biol Toxicol. 1992;8(3):93–100.1332807
   PubMed Web of Science ®Google Scholar
• Liu W, Teng L, Yu K, et al. Design of hydrogels of 5-hydroxymethyl tolterodine and their studies on pharmacokinetics, pharmacodynamics and transdermal mechanism. Eur J Pharm Sci. 2017;96:530–541. doi:10.1016/j.ejps.2016.10.02427789373
   PubMed Web of Science ®Google Scholar
• Shrotriya S, Ranpise N, Satpute P, Vidhate B. Skin targeting of curcumin solid lipid nanoparticles-engrossed topical gel for the treatment of pigmentation and irritant contact dermatitis. Artif Cells Nanomed Biotechnol. 2018;46(7):1471–1482. doi:10.1080/21691401.2017.137365928884598
   PubMed Web of Science ®Google Scholar
• Ng SF, Tan LS, Buang F. Transdermal anti-inflammatory activity of bilayer film containing olive compound hydroxytyrosol: physical assessment, in vivo dermal safety and efficacy study in Freund’s adjuvant-induced arthritic rat model. Drug Dev Commun. 2017;43(1):108–119.
   Google Scholar
• Nakamura Y, Kogure K, Futaki S, Harashima H. Octaarginine-modified multifunctional envelope-type nano device for siRNA. J Control Release. 2007;119(3):360–367. doi:10.1016/j.jconrel.2007.03.01017478000
   PubMed Web of Science ®Google Scholar
• Kang MH, Park MJ, Yoo HJ, et al. RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes for enhanced intracellular drug delivery to hepsin-expressing cancer cells. Eur J Pharm Biopharm. 2014;87(3):489–499. doi:10.1016/j.ejpb.2014.03.01624704199
   PubMedGoogle Scholar
• Verma P, Pathak K. Nanosized ethanolic vesicles loaded with econazole nitrate for the treatment of deep fungal infections through topical gel formulation. Nanomedicine. 2012;8(4):489–496. doi:10.1016/j.nano.2011.07.00421839053
   PubMed Web of Science ®Google Scholar
• Din FU, Mustapha O, Kim DW, et al. Novel dual-reverse thermosensitive solid lipid nanoparticle-loaded hydrogel for rectal administration of flurbiprofen with improved bioavailability and reduced initial burst effect. Eur J Pharm Biopharm. 2015;94:64–72. doi:10.1016/j.ejpb.2015.04.01925979136
   PubMed Web of Science ®Google Scholar
• Jaiswal M, Kumar A, Sharma S. Nanoemulsions loaded Carbopol® 934 based gel for intranasal delivery of neuroprotective Centella asiatica extract: in–vitro and ex–vivo permeation study. J Pharm Investig. 2016;46(1):79–89. doi:10.1007/s40005-016-0228-1
   Google Scholar
• Kaur L, Jain SK, Singh K. Vitamin E TPGS based nanogel for the skin targeting of high molecular weight anti-fungal drug: development and in vitro and in vivo assessment. RSC Adv. 2015;5(66):53671–53686. doi:10.1039/C5RA08374E
   Web of Science ®Google Scholar
• Zbytovská J, Raudenkolb S, Wartewig S, et al. Phase behaviour of transkarbam 12. Chem Phys Lipids. 2004;129(1):97–109. doi:10.1016/j.chemphyslip.2003.12.00414998731
   PubMedGoogle Scholar
• Thanou M, Florea BI, Langemeÿer MWE, Verhoef JC, Junginger HE. N-trimethylated chitosan chloride (TMC) improves the intestinal permeation of the peptide drug buserelin in vitro (Caco-2 cells) and in vivo (Rats). Pharm Res. 2000;17(1):27–31.10714604
   PubMed Web of Science ®Google Scholar
• Thanou MM, Kotzé AF, Scharringhausen T, et al. Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal caco-2 cell monolayers. J Control Release. 2000;64(3):15–25.10640642
   PubMed Web of Science ®Google Scholar
• Yang F, Zhang M, He W, et al. Controlled release of Fe3O4 nanoparticles in encapsulated microbubbles to tumor cells via sonoporation and associated cellular bioeffects. Small. 2011;7(7):902–910. doi:10.1002/smll.20100218521374806
   PubMedGoogle Scholar
• Patlolla RR, Desai P, Belay K, Singh M. Translocation of cell penetrating peptide engrafted nanoparticles across skin layers. Biomaterials. 2010;31(21):5598–5607. doi:10.1016/j.biomaterials.2010.03.01020413152
   PubMed Web of Science ®Google Scholar
• Jung S, Otberg N, Thiede G, et al. Innovative liposomes as a transfollicular drug delivery system: penetration into porcine hair follicles. J Invest Dermatol. 2006;126(8):1728–1732. doi:10.1038/sj.jid.570032316645589
   PubMed Web of Science ®Google Scholar
• Song YK, Kim CK. Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes. Biomaterials. 2006;27(2):271–280. doi:10.1016/j.biomaterials.2005.05.09716039711
   PubMed Web of Science ®Google Scholar
• Knorr F, Lademann J, Patzelt A, Sterry W, Blumepeytavi U, Vogt A. Follicular transport route–research progress and future perspectives. Eur J Pharm Biopharm. 2009;71(2):173–180. doi:10.1016/j.ejpb.2008.11.00119041720
   PubMed Web of Science ®Google Scholar
• Berg J, Fellier H, Christoph T, Grarup J, Stimmeder D. The analgesic NSAID lornoxicam inhibits cyclooxygenase (COX)-1/-2, inducible nitric oxide synthase (iNOS), and the formation of interleukin (IL)-6 in vitro. Inflamm Res. 1999;48(7):369–379. doi:10.1007/s00011005047410450786
   PubMed Web of Science ®Google Scholar
• Smith WL, Marnett LJ. Prostaglandin endoperoxide synthase: structure and catalysis. Biochim Biophys Acta. 1991;1083(1):1–17. doi:10.1016/0005-2760(91)90119-31903304
   PubMed Web of Science ®Google Scholar
• Smith WL. Prostanoid biosynthesis and mechanisms of action. Am J Physiol. 1992;263(2):181–191.
   Google Scholar
• Watkins LR, Maier SF, Goehler LE. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain. 1995;63(3):289–302.8719529
   PubMed Web of Science ®Google Scholar
• Anbar M, Gratt BM. Role of nitric oxide in the physiopathology of pain. J Pain Symptom Manage. 1997;14(4):225–254.9379070
   PubMed Web of Science ®Google Scholar
• Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol. 1996;14(11):397–440. doi:10.1146/annurev.immunol.14.1.3978717520
   PubMedGoogle Scholar
• Mello SBV, Barros DM, Silva ASF, Laurindo IMM, Novaes GS. Methotrexate as a preferential cyclooxygenase 2 inhibitor in whole blood of patients with rheumatoid arthritis. Rheumatology. 2000;39(5):533–536. doi:10.1093/rheumatology/39.5.53310852985
   PubMedGoogle Scholar
• Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med. 2001;344(12):907–916. doi:10.1056/NEJM20010322344120711259725
   PubMed Web of Science ®Google Scholar